119 related articles for article (PubMed ID: 22570519)
1. 3D-QSAR studies on fluroquinolones derivatives as inhibitors for tuberculosis.
Bhattacharjee A; Mylliemngap BJ; Velmurugan D
Bioinformation; 2012; 8(8):381-7. PubMed ID: 22570519
[TBL] [Abstract][Full Text] [Related]
2. 3d QSAR studies on a series of quinazoline derrivatives as tyrosine kinase (egfr) inhibitor: the k-nearest neighbor molecular field analysis approach.
Noolvi MN; Patel HM
J Basic Clin Pharm; 2010 Jun; 1(3):153-75. PubMed ID: 24825983
[TBL] [Abstract][Full Text] [Related]
3. 3D QSAR study on substituted 1, 2, 4 triazole derivatives as anticancer agents by kNN MFA approach.
Desai SP; Mohite SK; Alobid S; Saralaya MG; Patil AS; Das K; Almadani ME; Arif Hussain S; Hussain Alamer B; Abdulrahman Jibreel E; Ibrahim Almoteer A; Mohammed Basheeruddin Asdaq S
Saudi Pharm J; 2023 Dec; 31(12):101836. PubMed ID: 38028224
[TBL] [Abstract][Full Text] [Related]
4. Molecular modelling studies for the discovery of new substituted pyridines derivatives with angiotensin II AT1 receptor antagonists.
Sharma MC
Interdiscip Sci; 2014 Sep; 6(3):197-207. PubMed ID: 25205497
[TBL] [Abstract][Full Text] [Related]
5. Pharmacophore Identification and QSAR Studies on Substituted Benzoxazinone as Antiplatelet Agents: kNN-MFA Approach.
Choudhari PB; Bhatia MS; Jadhav SD
Sci Pharm; 2012; 80(2):283-94. PubMed ID: 22896816
[TBL] [Abstract][Full Text] [Related]
6. 2D and 3D-QSAR study on 4-anilinoquinozaline derivatives as potent apoptosis inducer and efficacious anticancer agent.
Vyas VK; Ghate M; Katariya H
Org Med Chem Lett; 2011 Oct; 1(1):13. PubMed ID: 22373168
[TBL] [Abstract][Full Text] [Related]
7. Comparative pharmacophore modeling and QSAR studies for structural requirements of some substituted 2-aminopyridines derivatives as inhibitors nitric oxide synthases.
Sharma MC
Interdiscip Sci; 2014 Sep; ():. PubMed ID: 25183347
[TBL] [Abstract][Full Text] [Related]
8. QSAR Studies on Neuraminidase Inhibitors as Anti-influenza Agents.
Veerasamy R; Rajak H
Turk J Pharm Sci; 2021 Apr; 18(2):151-156. PubMed ID: 33900700
[TBL] [Abstract][Full Text] [Related]
9. A QSAR analysis of 2-phenoxy-N-substituted acetamide analogues as hypoxia-inducible factor-1(HIF-1) inhibitors: a rational approach to anticancer drug design.
Noolvi MN; Patel HM; Kamboj S
Med Chem; 2012 Jul; 8(4):599-614. PubMed ID: 22530909
[TBL] [Abstract][Full Text] [Related]
10. A structure-activity relationship study of imidazole-5-carboxylic acids derivatives as angiotensin II receptor antagonists combining 2D and 3D QSAR methods.
Sharma MC
Interdiscip Sci; 2014 Sep; ():. PubMed ID: 25183352
[TBL] [Abstract][Full Text] [Related]
11. A Combined Approach of Pharmacophore Modeling, QSAR Study, Molecular Docking and In silico ADME/Tox Prediction of 4-Arylthio & 4-Aryloxy-3- Iodopyridine-2(1H)-one Analogs to Identify Potential Reverse Transcriptase Inhibitor: Anti-HIV Agents.
Panigrahi D; Mishra A; Sahu SK; Azam MA; Vyshaag CM
Med Chem; 2022; 18(1):51-87. PubMed ID: 33319692
[TBL] [Abstract][Full Text] [Related]
12. 3D-QSAR studies on CCR2B receptor antagonists: Insight into the structural requirements of (R)-3-aminopyrrolidine series of molecules based on CoMFA/CoMSIA models.
Gade S; Mahmood S
J Pharm Bioallied Sci; 2012 Apr; 4(2):123-33. PubMed ID: 22557923
[TBL] [Abstract][Full Text] [Related]
13. Discovery of potent antihypertensive ligands substituted imidazolyl biphenyl sulfonylureas analogs as angiotensin II AT
Sharma MC
Interdiscip Sci; 2014 Sep; ():. PubMed ID: 25183349
[TBL] [Abstract][Full Text] [Related]
14. Structure based 3D-QSAR studies of Interleukin-2 inhibitors: Comparing the quality and predictivity of 3D-QSAR models obtained from different alignment methods and charge calculations.
Halim SA; Zaheer-ul-Haq
Chem Biol Interact; 2015 Aug; 238():9-24. PubMed ID: 26051521
[TBL] [Abstract][Full Text] [Related]
15. 3D-QSAR and Molecular Docking Studies on Oxadiazole Substituted Benzimidazole Derivatives: Validation of Experimental Inhibitory Potencies Towards COX-2.
Asati V; Ghode P; Bajaj S; Jain SK; Bharti SK
Curr Comput Aided Drug Des; 2019; 15(4):277-293. PubMed ID: 30280671
[TBL] [Abstract][Full Text] [Related]
16. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
Kumari M; Chandra S; Tiwari N; Subbarao N
BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
[TBL] [Abstract][Full Text] [Related]
17. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
Bhongade BA; Gadad AK
J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Structural Basis for Thiazolopyridine Derivatives as DNA Gyrase-B Inhibitors.
Zambre VP; Petkar NN; Dewoolkar VP; Bhadke SV; Sawant SD
Curr Drug Discov Technol; 2023; 20(4):e220223213933. PubMed ID: 36815634
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds.
Ventura C; Latino DA; Martins F
Eur J Med Chem; 2013; 70():831-45. PubMed ID: 24246731
[TBL] [Abstract][Full Text] [Related]
20. Molecular Modeling Studies of Thiophenyl C-Aryl Glucoside SGLT2 Inhibitors as Potential Antidiabetic Agents.
Sharma MC; Sharma S
Int J Med Chem; 2014; 2014():739646. PubMed ID: 25574393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
